CNBC · Finance · 2026-08-17
This little-known cancer screening stock is about to get a big boost, Jefferies says
The investment firm initiated coverage of the disease-detection name at a buy. This little-known cancer screening stock is about to get a big boost, Jefferies says
Read original on CNBC Get the app
Licensed summary · LicensedSummary
Related briefs
- Trump, Carney reportedly in talks ahead of new 50% tariffs on Canadian goods
- U.S. government debt yields are surging at a bad time. Here's what's behind the move
- Apple overhauls Europe app store fees to resolve payments clash
- Jubilant Ingrevia shares to be in focus on Wednesday as company to acquire 40% stake in EDMS firm
- Stocks making the biggest moves midday: Meta, Amylyx, Baidu, Klarna, Coherent, Sandisk & more